Price$69.11+3.63 (+5.54%)
2026-06-052026-09-09
News · 26 weeks17-50%
2026-03-152026-09-06
Mix790d
- Market3(43%)
- SEC Filings3(43%)
- Insider1(14%)
Latest news
25 items- SECUtah Medical Products Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSFemcare Ltd Acquires Orion Medical Supplies Ltd in the UKSALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of Utah Medical Products, Inc. (NASDAQ:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.ORION is a niche assembler and distributor, primarily in the UK and Europe, of Harm Reduction medical devices. Harm Reduction refers to programs and practices that aim to minimize negative health, social and legal impacts associated with drug use, drug policies and drug laws. ORION's kits incorporate devices that are designed to reduce the spread of blood borne infections, harmful drug litter and overdose injuries
- SECSEC Form 10-Q filed by Utah Medical Products Inc.10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Announces Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard f
- SECUtah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted. Because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative
- INSIDERDirector Richins Paul O gifted 150 shares (SEC Form 4)4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- INSIDERPrincipal Financial Officer Koopman Brian gifted 50 shares, decreasing direct ownership by 6% to 782 units (SEC Form 4)4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- SECSEC Form SD filed by Utah Medical Products Inc.SD - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECSEC Form 10-Q filed by Utah Medical Products Inc.10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Announces Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtainin
- SECUtah Medical Products Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECUtah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2026SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole.Summary of results.The following is a summary comparison of 1Q 2026 with 1Q 2025 income statement measures:Revenues (Sales):(10.2%)Gross Profit (GP):( 4.6%)Operating Income (OI):(18.7%)Net Income (NI):(14.4%)Earnings Per Share (EPS):(
- SECSEC Form DEF 14A filed by Utah Medical Products Inc.DEF 14A - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECSEC Form 10-K filed by Utah Medical Products Inc.10-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Utah Medical Products Inc.SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)
- NEWSUtah Medical Products, Inc. Announces Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / February 4, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on April 3, 2026 to stockholders of record at the close of business on March 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for o
- SECUtah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUTMD Reports Year 2025 and Fourth Quarter Financial PerformanceSALT LAKE CITY, UT / ACCESS Newswire / January 29, 2026 / With some unexpected circumstances in 2025, Utah Medical Products, Inc (UTMD) did not achieve its beginning of year financial projections. Nevertheless the Company retained excellent profit margins, and increased its year-ending cash balances to $85.8 million despite paying $4.0 million in dividends to stockholders and repurchasing 4.5% (since the end of 2024) of its shares in the open market for $8.4 million.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousand
- INSIDERSEC Form 3 filed by new insider Timken Kevin3 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- INSIDERSEC Form 4 filed by Principal Financial Officer Koopman Brian4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)
- SECSEC Form 10-Q filed by Utah Medical Products Inc.10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- SECUtah Medical Products Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)
- NEWSUtah Medical Products, Inc. Appoints Director and Increases Quarterly DividendSALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors. Mr. Timken, who served as UTMD's outside legal counsel for over twenty years prior to his retirement in 2025, graduated with a J.D. degree from the University of Utah College of Law in 1997. The Board believes his robust understanding of the functional and strategic challenges that the Company faces will be integral for continuing UTMD's future excellent performance.In addition, the Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable
UTMD FAQ
6 questionsWhat does Utah Medical Products Inc. do?
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable...Where does UTMD stock trade?
Utah Medical Products Inc. (UTMD) is listed on NASDAQ.What sector and industry is UTMD in?
Utah Medical Products Inc. operates in the Health Care sector, Medical/Dental Instruments industry.Does UTMD pay a dividend?
Yes. UTMD's next ex-dividend date is 2026-09-17 with a declared cash dividend of $0.31 per share, payable 2026-10-05.What companies are similar to UTMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare UTMD side-by-side with any of them on Quantisnow.How can I track UTMD on Quantisnow?
Quantisnow aggregates Utah Medical Products Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow UTMD to receive live email and push alerts on every new disclosure.